… Rheumatology Convergence, this year taking place in Chicago. Established in 2005, the Evelyn V. Hess Award recognizes a clinical […]

A small percentage of rheumatology practices (7.1% and 10.1%, respectively) provided care for half of all Medicaid and highly socially

Nationwide Study Exposes Thrombosis Burden in SLE. 27 Oct 2025. Rheumatology · View All News. Hospital burden of thrombotic events

Current American College of Rheumatology, European Alliance of Associations for Rheumatology, and Kidney Disease: Improving Global Outcomes …

… Rheumatology (ACR) Convergence in Chicago, Illinois taking place from October 24-29, 2025. “The POETYK PsA-1 Week 52 data and

… Rheumatology Convergence 2025 … Rheumatology Convergence 2025. “Data from the CARLYSLE study shows that obe-cel has the potential to

Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with

Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual …

(NASDAQ: TNXP) presented clinical trial data for its fibromyalgia treatment Tonmya at the 2025 American College of Rheumatology Convergence in

… Rheumatology (ACR) Convergence, held October 24–29, 2025, in Chicago … Rheumatology criteria for fibromyalgia. Treatment with Tonmya …

Kymera Therapeutics (NASDAQ: KYMR) presented new preclinical data for KT-579, an oral IRF5 degrader, at the American College of Rheumatology

We collected audit data from patients aged 16 years and older who attended specialist rheumatology centres in England and Wales

… Rheumatology (ACR) Convergence 2025, currently underway in Chicago. The featured poster highlights findings from Citryll’s Phase I clinical trial …

Hospitals and specialized rheumatology centers provide improved access to clinical care, which strengthens treatment uptake across the region. In …

For rheumatologists, these data reinforce upadacitinib’s role as a viable and durable option for patients across multiple lines of therapy,

claire-daien-md-phd. Advertisement. Claire Daien, MD, PhD. Prof of Rheumatology at Université de Montpellier. Articles by Claire Daien, MD, PhD …